1. Home
  2. NUKK vs WHWK Comparison

NUKK vs WHWK Comparison

Compare NUKK & WHWK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nukkleus Inc.

NUKK

Nukkleus Inc.

HOLD

Current Price

$4.05

Market Cap

100.0M

Sector

Finance

ML Signal

HOLD

WHWK

Whitehawk Therapeutics Inc.

HOLD

Current Price

$2.40

Market Cap

95.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NUKK
WHWK
Founded
2013
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Blank Checks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
100.0M
95.2M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
NUKK
WHWK
Price
$4.05
$2.40
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$7.00
AVG Volume (30 Days)
955.2K
162.5K
Earning Date
02-09-2026
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$14,384,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.31
$1.39
52 Week High
$40.98
$3.81

Technical Indicators

Market Signals
Indicator
NUKK
WHWK
Relative Strength Index (RSI) 35.93 48.08
Support Level $3.88 $2.40
Resistance Level $4.95 $2.85
Average True Range (ATR) 0.43 0.16
MACD -0.07 -0.02
Stochastic Oscillator 10.70 23.77

Price Performance

Historical Comparison
NUKK
WHWK

About NUKK Nukkleus Inc.

Nukkleus Inc is a financial technology company that is focused on providing software and technology solutions. The company's operating segment includes General support services and Financial services. General support services include providing software, technology, customer sales and marketing, and risk management technology hardware and software solutions package under a GSA to a related party. Financial services include providing payment services from one fiat currency to another or to digital assets. It generates maximum revenue from the General support services segment. Geographically operates in USA, UK and Malta, with majority of revenue from United Kingdom (UK).

About WHWK Whitehawk Therapeutics Inc.

Whitehawk Therapeutics Inc is a preclinical stage oncology therapeutics. The company is engaged in applying technologies to established tumor biology to efficiently deliver improved cancer treatments. The company's three-asset ADC portfolio is engineered to overcome the limitations of first-generation predecessors to deliver a meaningful impact for patients with difficult-to-treat cancers.

Share on Social Networks: